1.31. Analysis.
Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 31 Relevant biomarker changes associated with the intervention (cord blood c‐peptide levels > 566 pmol/L).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.